Enlight Quickshot

DJI Announces Mini 4 Pro Drone, Upgraded DJI Mini Series; Learn More Info at B&H

Retrieved on: 
Tuesday, September 26, 2023
Online Retail, Consumer Electronics, Retail, Technology, Photography, Audio, Video, Specialty, FocusTrack, Portrait, Mini, Enlight Quickshot, Social media, ND, Noise, Aircraft, DJI, Orientation, ISO, Video game, Panorama

However, the Mini 4 Pro can now achieve 100 fps slow motion in stunning 4K.

Key Points: 
  • However, the Mini 4 Pro can now achieve 100 fps slow motion in stunning 4K.
  • Ease of use is a hallmark of the Mini line, and the Mini 4 Pro continues this with a compact and foldable design that weighs roughly 8.8 oz.
  • With the Mini 4 Pro, a new addition is ActiveTrack’s Trace Mode and an ability to fly specific routes when tracking, compared to Mini 3 Pro’s fixed direction tracking.
  • With the release of the Mini 4 Pro, DJI continues the Mini series tradition of offering all skill levels a compact and capable aerial imaging solution.

DJI Announces Air 3 Drone--the First Air Drone to Feature Dual Cameras; First-Look YouTube Video at B&H

Retrieved on: 
Tuesday, July 25, 2023
Comp Air 3, FocusTrack, Waypoint, ND, Enlight Quickshot, The Folk of the Air (series), Atmosphere of Earth, DJI, Aircraft, Airline, Video game, Camera, Hyperlapse

NEW YORK, July 25, 2023 /PRNewswire/ -- B&H is pleased to announce the release of the DJI Air 3 Drone. As the successor to the Air 2S, the Air 3 brings the Air series closer to the more advanced Mavic, while still being accessible to beginner pilots and professionals alike. Equipped with many firsts for the Air series, the Air 3 offers a dual camera system, with wide-angle and 3x telephoto cameras, as well as a longer 12.4-mile range O4 transmission system, longer 46-minute flight time, smoother APAS 5.0 obstacle avoidance, and the incorporation of the Waypoint feature for custom flight planning.

Key Points: 
  • The foldable design makes the drone compact, letting pilots take the DJI Air 3 almost anywhere, and deploy at a moment's notice.
  • Various flight modes, such as FocusTrack, QuickShots, MasterShots, and Hyperlapse deliver pre-programmed creative flight maneuvers and tracking for professional results that are more easily achievable.
  • Part of Hyperlapse is the Waypoint feature, which is new to the Air 3.
  • In any format, the Air 3 represents a significant leap forward in capabilities, while staying accessible to all skill levels.

DJI Mini & Mavic Sales & Deals List (March 2023) Highlighted by Deal Stripe

Retrieved on: 
Saturday, March 11, 2023
Technology, Drones, Enlight Quickshot, Mavic (unmanned aerial vehicle), Walmart, Mini, DJI, Stripe, Mavic

Deal Stripe may earn commissions from sales generated using the links provided.

Key Points: 
  • Deal Stripe may earn commissions from sales generated using the links provided.
  • DJI is a leading manufacturer of drones and aerial photography equipment, offering a wide range of products suitable for both professional and recreational use.
  • The DJI Mini and Mavic series are two of the company's most popular and innovative drone lines.
  • Whether you're a beginner or an experienced drone user, DJI's Mini and Mavic series offer a range of high-quality options for your aerial photography needs.

Purinergic Receptor (Purinoceptor) Antagonists Drug Pipeline Market Research Report 2022 - ResearchAndMarkets.com

Retrieved on: 
Thursday, February 3, 2022
Health, Pharmaceutical, MSD, Merck & Co., Antares (rocket), Food, UCC, Clinical trial, Discovery, Gefapixant, Chronic cough, II, Partnership, New Drug Application, RCC, Mergers and acquisitions, News, Acquisition, Merck, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, FDA, NDA, Therapy, Enlight Quickshot, Review, Myocardial infarction, Fine chemical, Pharmaceutical industry, Purinergic receptor

The "Purinergic Receptor (Purinoceptor) Antagonists - Pipeline Insight, 2022" clinical trials has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Purinergic Receptor (Purinoceptor) Antagonists - Pipeline Insight, 2022" clinical trials has been added to ResearchAndMarkets.com's offering.
  • This "Purinergic Receptor (Purinoceptor) Antagonists - Pipeline Insight, 2022" report provides comprehensive insights about 40+ companies and 40+ pipeline drugs in Purinergic Receptor (Purinoceptor) Antagonists pipeline landscape.
  • The companies and academics are working to assess challenges and seek opportunities that could influence Purinergic Receptor (Purinoceptor) Antagonists R&D.
  • This segment of the report provides insights about the different Purinergic Receptor (Purinoceptor) Antagonists drugs segregated based on following parameters that define the scope of the report.

Antares Pharma Reports Second Quarter 2021 Financial and Operating Results

Retrieved on: 
Thursday, August 5, 2021
Company, PK, Pfizer, Research, U.S. Securities and Exchange Commission, Testosterone, Forward-looking statement, Industry, Prescription, Eastern Time Zone, Annual report, Eastern, Antares, Private Securities Litigation Reform Act, IND, Review, Hydrocortisone, Growth, Patient, AMAG, COVID-19, Letter, Ferring Pharmaceuticals, GLOBE, Total, Enlight Quickshot, Food and Drug Administration, Net income, Terminology, NDA, Income, Marketing, AMAG Pharmaceuticals, Nasdaq, Security (finance), Risk, Pharmaceutical industry, Lithium, Music, Animal

EWING, N.J., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a specialty pharmaceutical company, today reported financial and operating results for the second quarter ended June 30, 2021 with record revenue of $45.0 million and net income of $4.4 million, or $0.03 per basic and diluted earnings per share.

Key Points: 
  • Robert F. Apple, President and Chief Executive Officer of Antares Pharma, commented, We believe our strong second quarter performance highlights the growth opportunities that prevail across our diversified business.
  • XYOSTED total prescriptions in the second quarter 2021 increased 50% year-over-year and 15% sequentially from first quarter 2021, according to IQVIA.
  • In June 2021, Antares made a $15.0 million principal prepayment and reduced our loan balance with Hercules Capital to $25.0 million.
  • The Antares management team will provide a Company update and review the second quarter and year-to-date financial results via conference call and webcast today, August 5, 2021, at 8:30am ET (Eastern Time).